Abstract |
An investigator-blinded, randomized, multicenter study was conducted to compare the efficacy and safety of cefdinir and amoxicillin/ clavulanate ( amoxicillin/CA) in the treatment of pediatric patients with acute suppurative otitis media. Patients 6 months to 12 years of age were randomized in a 1:1:1 ratio to receive cefdinir 14 mg/kg once-daily, cefdinir 7 mg/kg b.i.d., or amoxicillin/CA 13.3 mg/kg t.i.d. Test-of-cure was determined 11 to 16 days posttherapy. Of the 752 patients who entered the study, 665 (88%) completed treatment and 595 (79%) were evaluable. Response rates in the three treatment groups were similar. Overall rates of adverse events were statistically lower in the cefdinir once-daily group than in the amoxicillin/CA group. Diarrhea was the most common adverse event in all treatment groups. Cefdinir given either once-daily or twice-daily is a safe and effective treatment for pediatric patients with acute suppurative otitis media.
|
Authors | M Adler, P J McDonald, U Trostmann, C Keyserling, K Tack |
Journal | The Pediatric infectious disease journal
(Pediatr Infect Dis J)
Vol. 19
Issue 12 Suppl
Pg. S166-70
(Dec 2000)
ISSN: 0891-3668 [Print] United States |
PMID | 11144399
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cephalosporins
- Amoxicillin-Potassium Clavulanate Combination
- Cefdinir
|
Topics |
- Acute Disease
- Amoxicillin-Potassium Clavulanate Combination
(administration & dosage, therapeutic use)
- Cefdinir
- Cephalosporins
(administration & dosage, therapeutic use)
- Child
- Child, Preschool
- Drug Therapy, Combination
(administration & dosage, therapeutic use)
- Female
- Humans
- Infant
- Male
- Otitis Media, Suppurative
(drug therapy)
- Treatment Outcome
|